Skip to content
DataLookout
Start free
Menu

EATAFNCT07849777

Early Anticoagulation Therapy After Endovascular Treatment for Acute Ischemic Stroke With Atrial Fibrillation

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Hao Yonggang to The Fourth Affiliated Hospital of Soochow University
    • Site contacts updated at 2 of 2 sites
    • Collaborators expanded, about 2 words
  2. Study sites: 1 to 2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Functional independence (90-day mRS score ≤ 1)
Timeframe: At 90 days after randomization

Secondary (11)

Composite outcome of recurrent ischemic stroke, symptomatic intracranial hemorrhage, or all-cause mortality within 90 days
Recurrent ischemic stroke within 90 days
Venous thromboembolic events within 90 days
Systemic embolic events within 90 days
Myocardial infarction within 90 days
Show 6 moreShow less
Favorable functional outcome (90-day mRS score ≤ 2)
Symptomatic intracranial hemorrhage within 90 days
Health-related quality of life at 90 days, assessed using the EQ-5D-3L questionnaire
Major extracranial bleeding within 90 days
All-cause mortality within 90 days
Vascular mortality within 90 days

Arms and interventions

Early Initiation of DOAC TherapyExperimental
Antiplatelet Bridging Followed by DOAC TherapyExperimental

Other: Early Initiation of DOAC Therapy, Antiplatelet Bridging Followed by DOAC Therapy

Sites

2 sites in 1 country